Key result
This review outlines the indications for ACE inhibitors and ARBs and provides guidance on managing their adverse effects, specifically declining renal function and hyperkalemia.
Why the study?
To review indications for ACE inhibitors and ARBs and provide guidance on managing adverse effects such as declining renal function and hyperkalemia.
This review provides guidance on managing common adverse effects, specifically declining renal function and hyperkalemia, associated with ACE inhibitor and ARB therapy.
Answers are grounded in this paper and cite their sources.
Guides ACE inhibitor and ARB use amid common adverse effects; leaves open need for prospective validation of recommendations.
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are used primarily to treat hypertension and are also useful for conditions such as heart failure and chronic kidney disease, independent of their effect on blood pressure. This article reviews the indications for ACE inhibitors and ARBs and offers advice for managing their adverse effects, particularly declining renal function and hyperkalemia.
No takes yet. Share an insight, caveat, or question.
Momoniat et al. (2019) conducted a review in Hypertension, heart failure, and chronic kidney disease. ACE inhibitors and ARBs was evaluated. This review outlines the indications for ACE inhibitors and ARBs and provides guidance on managing their adverse effects, specifically declining renal function and hyperkalemia.
Synapse has enriched 10 related papers. Consider them for comparative context: